340B Drug Pricing Program
On Nov. 2, the Centers for Medicare & Medicaid Services issued its calendar year 2019 outpatient prospective payment system /ambulatory surgical center final rule. In addition to standard updates, the rule expands Medicare “site-neutral” payment policies and changes the payment policies for…
Facing deadlines for responding to the lawsuit brought by the AHA, Association of American Medical Colleges, America's Essential Hospitals, 340B Health and three hospital systems, the Health Resources and Services Administration proposes a Jan. 1 compliance date for its final rule on 340B drug…
A federal court today denied the Department of Health and Human Services’ motion for a stay in a lawsuit challenging the excessive delay in the effective date for the 340B price transparency rule.
Tom Nickels
Executive Vice President
The Department of Health and Human Services today proposed implementing on Jan. 1 its final rule on 340B drug ceiling prices and civil monetary penalties for manufacturers.
Melinda Hatton
On October 25, the Centers for Medicare & Medicaid Services issued an advance notice of proposed rulemaking to solicit public comments on potential options for testing a new model for paying for prescription drugs under Medicare Part B provided in physician offices, hospital outpatient…
AHA v. The Department of Health and Human Services Reply in Support of Defendants' Motion for a Stay
IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF COLUMBIA
THE AMERICAN HOSPITAL ASSOCIATION, et al., Plaintiffs,
v.
THE DEPARTMENT OF HEALTH AND HUMAN SERVICES, et al., Defendants.
No. 1:18-cv-02112-JDB
REPLY IN SUPPORT OF DEFENDANTS’ MOTION FOR A STAY
The AHA and other hospital groups today opposed the Department of Health and Human Services motion to stay in the groups’ lawsuit challenging the excessive delay in the effective date for the 340B price transparency rule.